vinpocetine derivatives (Takeda)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug Namevinpocetine derivatives (Takeda)
Drug Alias NameAlzheimers therapy (Takeda)Eburnamenine-14-carboxylic acid, ethyl ester, (3.alpha.,16.alpha.)-; vinpocetine derivatives (Takeda)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAdrenergic receptor alpha-1 antagonists
TargetsAdrenergic receptors alpha-1
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTakeda Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTakeda Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A